As Covid-19 cases continue to increase across the globe, advanced gas process system manufacturer Oxair is offering its oxygen pressure swing adsorption (PSA) to those who need a continuous oxygen supply.
With continuing worries surrounding oxygen supply, the Australia-based company with its manufacturing facility in Australia and India can turn around orders for ready-to-use, standalone oxygen PSA units in about eight to ten weeks, depending on local lockdown laws or travel restrictions.
A key piece of equipment in the fight against Covid-19, PSA oxygen offers patient care with a permanent flow of high-quality oxygen – in Oxair’s case a plug and play system with output pressure of four bar and a flow rate to suit the needs of the hospital.
The system delivers constant oxygen of 94-95 percent purity through PSA filtration, a unique process that separates oxygen from compressed air. The gas is then conditioned and filtered before being stored in a buffer tank to be used directly by the end user on demand.
... to continue reading you must be subscribed
